Found 0 matching trials
Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA (Enteric Coated Mycophenolic Acid) Following Liver Transplantation PHASE4 This is an investigator initiated study at the University of California, Lo...
Show More Location
Ronald Reagan UCLA Medical Center
Learn More & Join Trial
Safety and Efficacy Study of Thymoglobulin Versus IL2 Receptor Antagonists NA The purpose of this study is to evaluate the safety and efficacy of inducti...
Show More Location
Medical University of South Carolina
Learn More & Join Trial
Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes NA This is a single-center, phase IIT clinical trial to evaluate autologous re...
Show More Location
Shanghai Changzheng Hospital
Learn More & Join Trial
Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR PHASE4 The purpose of this study is to determine if the combination of once-daily ...
Show More Location
University of Southern California
Learn More & Join Trial
Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy PHASE2 The 3C study is investigating whether reducing exposure to calcineurin inhi...
Show More Location
Oxford Radcliffe Hospitals NHS Trust
Learn More & Join Trial
Initiation of a Deceased Donor Uterine Transplantation Program at the University of Nebraska Medical Center NA This study will explore the feasibility of initiating a uterine transplant ...
Show More Location
Multiple Locations
Learn More & Join Trial
Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment PHASE4 IgA nephropathy (IgAN) is a histologically defined glomerulonephritis (rena...
Show More Learn More & Join Trial
Study Evaluating Sirolimus in Kidney Transplant Recipients. PHASE3 Renal function at 12 months assessed by calculated creatinine clearance....
Location
Multiple Locations
Learn More & Join Trial
Induction Therapy With Autologous Mesenchymal Stem Cells for Kidney Allografts NA The goal of this study is to evaluate autologous MSCs as an alternative for...
Show More Location
Stem cell therapy center,Fuzhou General Hospital
Learn More & Join Trial
Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients PHASE2 This study was to compare CFZ533 to tacrolimus (TAC) in prevention of organ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial